Greater Glasgow and Clyde Medicines

New clinical guideline - Proton Pump Inhibitor Guideline for Neonates and Paediatrics. The guideline contains information on preferred choice of PPI, as well as dosage and administration advice.

The carbon footprint of inhalers was considered during the recent review of the NHSGGC COPD and adult asthma inhaler device guides (IDGs) (available on StaffNet). The IDGs now have a traffic light key which highlights if the inhaler has a very high, high or low carbon footprint.

Guideline News for October 2021

MHRA Drug Safety Update for October 2021

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines assessed by SMC and considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary

This update covers local formulary changes and decisions not related to recent SMC advice such as formulary appeals, new drug assessments and formulary section reviews

Guideline News for September 2021

Key Medicine Shortages for September 2021

Sevodyne® is now NHSGGC Preferred brand of buprenorphine 7 day transdermal patches

MHRA Drug Safety Update September 2021